Development of a Patient-Reported Outcome Measure for Geriatric Care: The Older Persons and Informal Caregivers Survey Short Form

Santoso, Angelina M M; Lutomski, Jennifer E.; Hofman, Cynthia; Metzelthin, Silke; Blom, Jeanet W.; Wees, Philip J. van der; Rikkert, Marcel G M Olde; Melis, René J. F.

doi:10.1016/j.jval.2018.02.011

Cited by 20 publications

(20 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Fifteen studies reported the mean age for caregivers that ranged from 44 years to 70 years . Clinical populations under investigation were stroke survivors and their caregivers in 21 studies (21/23 [91%]) . Two studies investigated older people admitted to the hospital, irrespective of medical diagnosis .…”

Section: Resultsmentioning

confidence: 99%

“…The primary outcome measure was patient HRQOL. This is justified given the reported importance of patient HRQOL as a meaningful outcome shared by both patient and caregiver . Secondary outcome measures included caregiver HRQOL, caregiver burden, patient function, patient and caregiver anxiety and depression, adverse events (including falls, delirium, medical complications, delayed hospital discharge, and emergency department/hospital readmission), and cost effectiveness/health resource utilization.…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Caregiver Interventions for Adults Discharged from the Hospital: Systematic Review and Meta‐Analysis

Smith

Pearson

Pfeiffer

et al. 2019

J American Geriatrics Society

View full text Add to dashboard Cite

OBJECTIVES To review the evidence evaluating the effectiveness of informal caregiver interventions to facilitate the recovery of older people discharged from the hospital. DESIGN Systematic review and meta‐analysis. SETTING Hospital and community. METHODS Published and unpublished randomized and nonrandomized controlled trials assessing the effectiveness of informal caregiver interventions to support the recovery of older people discharged from the hospital were identified (to March 2019). The primary outcome was patient health‐related quality of life (HRQOL). Secondary outcomes included patient function, caregiver burden, caregiver HRQOL, psychological distress, adverse events, and health resource use. Studies were critically appraised and meta‐analyzed. PARTICIPANTS Adults who had been admitted to the hospital. RESULTS A total of 23 studies were eligible (4695 participants). The indication for hospital admission was stroke in 21 trials (91%). Interventions consisted of training and/or skills‐based programs, with or without home visits/telephone follow‐up. Caregiver interventions for patients following stroke may provide no benefit for patient HRQOL at 12 months (standardized mean difference = .29; 95% confidence interval = ‐.12 to .69; low‐quality evidence). Caregiver interventions demonstrated benefit for caregiver burden and both patient and caregiver anxiety at 12 months. No consistent effect was found on functional outcomes, depression, HRQOL, adverse events, or health resource use measures. CONCLUSIONS Informal caregivers who receive training to facilitate the recovery of older people discharged from the hospital following stroke may have a lower burden and reduced anxiety at 12 months compared with those who do not. However, the evidence was moderate to low quality. Further study is warranted to explore whether caregiver interventions can be modified for nonstroke populations such as those with hip fracture. J Am Geriatr Soc 67:1960–1969, 2019

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Caregiver Interventions for Adults Discharged from the Hospital: Systematic Review and Meta‐Analysis

Smith

Pearson

Pfeiffer

et al. 2019

J American Geriatrics Society

View full text Add to dashboard Cite

show abstract

“…TOPICS-SF is a newer instrument designed to assess physical and mental health and quality of life in the elderly, for use in evaluating patient-reported outcomes in geriatric care. 43 TOPICS-SF includes questions on general health, pain, cognitive function, mood, activities of daily living and social activities.…”

Section: Discussionmentioning

confidence: 99%

Rationale and design of the EMPA-ELDERLY trial: a randomised, double-blind, placebo-controlled, 52-week clinical trial of the efficacy and safety of the sodium–glucose cotransporter-2 inhibitor empagliflozin in elderly Japanese patients with type 2 diabetes

et al. 2021

View full text Add to dashboard Cite

IntroductionElderly people (≥65 years) with type 2 diabetes mellitus (T2DM) are becoming increasingly prevalent, notably in Japan. As cardiovascular (CV) risk increases with age and sodium–glucose cotransporter-2 (SGLT2) inhibitors reduce CV risk, elderly patients with T2DM are increasingly likely to be prescribed these glucose-lowering drugs. There is controversy surrounding the effects of SGLT2 inhibitors on muscle mass, particularly in elderly patients for whom loss of muscle is especially undesirable; however, robust evidence on this important issue is lacking. Consequently, we have designed a clinical trial of the SGLT2 inhibitor empagliflozin in elderly Japanese patients with T2DM (Empagliflozin in Elderly T2DM Patients (EMPA-ELDERLY)) to assess its effects on body composition as well as glycaemic control. EMPA-ELDERLY will be the first randomised clinical trial of an SGLT2 inhibitor in elderly patients with T2DM to evaluate effects on skeletal muscle mass, muscle strength and physical performance concurrently.Methods and analysisEMPA-ELDERLY is a randomised, double-blind, placebo-controlled, parallel-group clinical trial to be conducted in Japan. Patients with T2DM aged ≥65 years are eligible if they are Japanese with a body mass index of ≥22 kg/m2 and glycated haemoglobin (HbA1c) levels from ≥7.0% to ≤10.0% from either diet and exercise alone or treatment with oral glucose-lowering drugs. Approximately 128 participants will be randomised 1:1 to once per day, oral, double-blind treatment with empagliflozin 10 mg or matching placebo for 52 weeks. The primary endpoint is the change in HbA1c level from baseline at week 52. Secondary endpoints include changes from baseline to 52 weeks in body composition, including muscle mass and body fat, measured by bioelectrical impedance analysis, as well as skeletal muscle index, grip strength and time in the five-time chair stand test. Other endpoints include changes in patient-reported outcomes (including quality of life), cognitive function and safety.Ethics and disseminationWe will submit the trial results to conferences and peer-reviewed journals.Trial registration numberNCT04531462.

show abstract

“…The questionnaire results are used to generate a Frailty Index (FI), which is calculated as the summation of the values associated with each answer, divided by the total of answered questions. The feasibility, validity, and reliability of the instrument as a frailty questionnaire has been established in previous studies [ 24 , 25 ]. It has also been validated as a PROM [ 23 ].…”

Section: Methodsmentioning

confidence: 99%

“…It has also been validated as a PROM [ 23 ]. The TOPICS-SF is currently accepted by the Dutch Geriatrics Society as a PROM for older patients throughout the Netherlands, and it is being implemented within several hospitals throughout the country [ 25 ]. The TOPICS-SF is included in Multimedia Appendix 2 .…”

Section: Methodsmentioning

confidence: 99%

Quality of Care Perceived by Older Patients and Caregivers in Integrated Care Pathways With Interviewing Assistance From a Social Robot: Noninferiority Randomized Controlled Trial

Boumans¹,

Meulen²,

Aalst³

et al. 2020

J Med Internet Res

View full text Add to dashboard Cite

Background Society is facing a global shortage of 17 million health care workers, along with increasing health care demands from a growing number of older adults. Social robots are being considered as solutions to part of this problem. Objective Our objective is to evaluate the quality of care perceived by patients and caregivers for an integrated care pathway in an outpatient clinic using a social robot for patient-reported outcome measure (PROM) interviews versus the currently used professional interviews. Methods A multicenter, two-parallel-group, nonblinded, randomized controlled trial was used to test for noninferiority of the quality of care delivered through robot-assisted care. The randomization was performed using a computer-generated table. The setting consisted of two outpatient clinics, and the study took place from July to December 2019. Of 419 patients who visited the participating outpatient clinics, 110 older patients met the criteria for recruitment. Inclusion criteria were the ability to speak and read Dutch and being assisted by a participating health care professional. Exclusion criteria were serious hearing or vision problems, serious cognitive problems, and paranoia or similar psychiatric problems. The intervention consisted of a social robot conducting a 36-item PROM. As the main outcome measure, the customized Consumer Quality Index (CQI) was used, as reported by patients and caregivers for the outpatient pathway of care. Results In total, 75 intermediately frail older patients were included in the study, randomly assigned to the intervention and control groups, and processed: 36 female (48%) and 39 male (52%); mean age 77.4 years (SD 7.3), range 60-91 years. There was no significant difference in the total patient CQI scores between the patients included in the robot-assisted care pathway (mean 9.27, SD 0.65, n=37) and those in the control group (mean 9.00, SD 0.70, n=38): P=.08, 95% CI –0.04 to 0.58. There was no significant difference in the total CQI scores between caregivers in the intervention group (mean 9.21, SD 0.76, n=30) and those in the control group (mean 9.09, SD 0.60, n=35): P=.47, 95% CI –0.21 to 0.46. No harm or unintended effects occurred. Conclusions Geriatric patients and their informal caregivers valued robot-assisted and nonrobot-assisted care pathways equally. Trial Registration ClinicalTrials.gov NCT03857789; https://clinicaltrials.gov/ct2/show/NCT03857789

show abstract

Development of a Patient-Reported Outcome Measure for Geriatric Care: The Older Persons and Informal Caregivers Survey Short Form

Cited by 20 publications

References 22 publications

Caregiver Interventions for Adults Discharged from the Hospital: Systematic Review and Meta‐Analysis

Caregiver Interventions for Adults Discharged from the Hospital: Systematic Review and Meta‐Analysis

Rationale and design of the EMPA-ELDERLY trial: a randomised, double-blind, placebo-controlled, 52-week clinical trial of the efficacy and safety of the sodium–glucose cotransporter-2 inhibitor empagliflozin in elderly Japanese patients with type 2 diabetes

Quality of Care Perceived by Older Patients and Caregivers in Integrated Care Pathways With Interviewing Assistance From a Social Robot: Noninferiority Randomized Controlled Trial

Contact Info

Product

Resources

About